Clinuvel Pharmaceuticals Ltd News - UR9 | Aktien Tradegate (DE)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025

MELBOURNE, Australia, March 03, 2025 (GLOBE NEWSWIRE) -- World-leading photomedicine company CLINUVEL will...

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

MELBOURNE, Australia, Oct. 01, 2024 (GLOBE NEWSWIRE) -- CLINUVEL has filed a New Drug Submission (NDS) to...

Afamelanotide in fair-skinned Parkinson’s patients

MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program...

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL...

Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga

Emittent / Herausgeber: CLINUVEL PHARMACEUTICALS LTD / Schlagwort(e): Sonstiges Biotech-Unternehmen CLINUVEL...

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an...

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

UV, HEV protection for individuals at high risk of photoageing and skin cancer MELBOURNE, Australia, March...

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

MELBOURNE, Australia, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Executive summaryPositive Results in the Half Year to...

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

MELBOURNE, Australia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Results released today from a clinical study have...

CLINUVEL Trial Results Show Drug Reduces DNA Damage

MELBOURNE, Australia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Results from a clinical trial in a genetic DNA repair...

CLINUVEL progresses vitiligo treatment program

MELBOURNE, Australia, May 09, 2022 (GLOBE NEWSWIRE) -- A new potential therapy for the pigment loss disorder...

Positive final results in stroke

ASX: XETRA-DAX: Level 1 ADR:CUV UR9 CLVLY EXECUTIVE SUMMARY afamelanotide evaluated as safe in mild to...

Letter to shareholders from CLINUVEL’s CEO

LONDON, April 29, 2022 (GLOBE NEWSWIRE) -- Dear shareholders, friends, Both from a professional...

CLINUVEL Expands Pharmaceutical Portfolio

MELBOURNE, Australia, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CLINUVEL has expanded its pharmaceutical development...

CLINUVEL expands DNA Repair Program

SCENESSE® (afamelanotide 16mg) to be evaluated in xeroderma pigmentosum variant (XP-V) MELBOURNE, Australia...

Rendering Error

Error: 507

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clinuvel Pharmaceuticals Ltd (UR9)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

UR9 Nachrichten

Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

Afamelanotide in fair-skinned Parkinson’s patients

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

CLINUVEL Trial Results Show Drug Reduces DNA Damage

CLINUVEL progresses vitiligo treatment program

Positive final results in stroke

Letter to shareholders from CLINUVEL’s CEO

CLINUVEL Expands Pharmaceutical Portfolio

CLINUVEL expands DNA Repair Program

UR9 Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clinuvel Pharmaceuticals Ltd (UR9) News

Clinuvel Pharmaceuticals Ltd (UR9)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

UR9 Nachrichten

Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

Afamelanotide in fair-skinned Parkinson’s patients

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga

Malibu shines a light on CLINUVEL’s pioneering work in photomedicine

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

CLINUVEL Trial Results Show Drug Reduces DNA Damage

CLINUVEL progresses vitiligo treatment program

Positive final results in stroke

Letter to shareholders from CLINUVEL’s CEO

CLINUVEL Expands Pharmaceutical Portfolio

CLINUVEL expands DNA Repair Program

UR9 Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen